TLDR
- Amesite (AMST) stock rose 190% in pre-market trading Tuesday after landing its largest institutional client to date.
- The client will deploy NurseMagic AI documentation across a workforce serving approximately 2,700 patients.
- The platform will be integrated with electronic medical records (EMR) and electronic visit verification (EVV) systems.
- The deployment is designed to reduce caregiver documentation time by up to 16 hours per week per worker.
- Amesite also reported an 18% decline in operating spending over the past six quarters.
Amesite Inc. announced On May 18, 2026 it secured a new home care customer – its largest to date – for its NurseMagic AI documentation platform. The news sent AMST stock soaring 190% in premarket trading on Tuesday.
The client serves approximately 2,700 patients and will roll out NurseMagic across its entire workforce. The platform will be linked to both electronic medical records and electronic visit verification systems.
The primary promise of publishing is to save time. Documentation can currently take up to 16 hours per caregiver per week, and NurseMagic is designed to significantly reduce this burden.
CEO and founder Dr. Anne-Marie Sastre put it clearly: “Publishing a census of 2,700 underscores the strength of our structure.” She added that the company can launch new clients quickly without the consulting fees and custom development costs typical of legacy providers.
Deployment supports multiple user roles, multi-layered permissions, and custom documentation across thousands of patients — without a lengthy onboarding process, Amesite says, that can take weeks or months with older systems.
The financials show discipline as well as growth
The win comes as Amesite tightens its cost structure. Sarah Berman, chief financial and accounting officer, noted a roughly 18% decline in operating spending over the past six quarters, even as the company grew its paying customer base.
This kind of efficiency coupled with expansion does not go unnoticed for penny stocks. Amesite’s market cap currently stands at around $4.48 million, putting any real win for an organization into great financial relief.
Sales and marketing efforts generate approximately 4,200 web visits per day, company operations manager Madison Bush reported. She also noted that more than 70% of leads participating in active discussions have self-scheduled demos through the website.
The pipeline points to more deals
In addition to the current deployment, Amesite says it is in discussions with additional organizations representing several thousand patients in total. The company did not name these potential customers or give a timeline.
NurseMagic serves more than 100 professions in 50 states and 21 countries. The platform supports multilingual capabilities and is compliant with HIPAA regulations.
The stock’s average daily trading volume is about 682,000. Technical sentiment for the stock is currently rated at Sell, although that rating was issued prior to Tuesday’s announcement.
The 2,700-patient deployment is the company’s largest and, according to management, represents NurseMagic’s transition from an adjunct to what they describe as core clinical infrastructure in the non-acute care market.
🚨 Our May Stock Picks are now available!
A new month means new opportunities. Our analysts just released their top stock picks for May, highlighting companies with strong momentum that rank highly in our KO Score algorithm. We also now share trading ideas for both long and short term investors, giving you more ways to discover potential market opportunities.
Sign up for Knockout Stocks today And get a 50% discount to open the full list and see the discounted stocks.
Use coupon code Special50 To get your exclusive discount!
